KD

Kinjalben Dineshbhai Chaudhary

Active Director Director DIN 11204131
DIN 11204131 First appointment Oct 2025 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Kinjalben Dineshbhai Chaudhary

Data last updated:

Kinjalben Dineshbhai Chaudhary is a Director at Pramukh Cancer And Research Institute Private Limited (since 2025). The company operates in Healthcare.

DIN 11204131
Primary Designation Director
Industry Healthcare
First Appointment 25 Oct 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director25 Oct 20252024Active

Directorship timeline

Open interactive timeline →
Pramukh Cancer And Research Institute Private Limited
Premium access

Shareholding and investment profile for Kinjalben Dineshbhai Chaudhary

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kinjalben Dineshbhai Chaudhary

Kinjalben Dineshbhai Chaudhary currently holds 1 directorship: Pramukh Cancer And Research Institute Private Limited (Director, since 25 Oct 2025).

Kinjalben Dineshbhai Chaudhary was first appointed on 25 Oct 2025 as Director at Pramukh Cancer And Research Institute Private Limited.

The current boards of Kinjalben Dineshbhai Chaudhary's companies include Dineshbhai Mansangbhai Chaudhary (Pramukh Cancer And Research Institute Private Limited), Hinaben Vasantkumar Patel (Pramukh Cancer And Research Institute Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available